JP2005519590A5 - - Google Patents

Download PDF

Info

Publication number
JP2005519590A5
JP2005519590A5 JP2003556018A JP2003556018A JP2005519590A5 JP 2005519590 A5 JP2005519590 A5 JP 2005519590A5 JP 2003556018 A JP2003556018 A JP 2003556018A JP 2003556018 A JP2003556018 A JP 2003556018A JP 2005519590 A5 JP2005519590 A5 JP 2005519590A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
polypeptide
seq
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003556018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519590A (ja
Filing date
Publication date
Priority claimed from PCT/US2001/027099 external-priority patent/WO2002024888A2/en
Priority claimed from US10/136,574 external-priority patent/US7419799B2/en
Application filed filed Critical
Publication of JP2005519590A publication Critical patent/JP2005519590A/ja
Publication of JP2005519590A5 publication Critical patent/JP2005519590A5/ja
Pending legal-status Critical Current

Links

JP2003556018A 2001-08-29 2002-07-30 免疫関連疾患の治療のための組成物及び方法 Pending JP2005519590A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2001/027099 WO2002024888A2 (en) 2000-09-01 2001-08-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same
US10/136,574 US7419799B2 (en) 2001-08-29 2002-04-29 Compositions and methods for the treatment of immune related diseases
PCT/US2002/024252 WO2003055440A2 (en) 2001-08-29 2002-07-30 Compositions and methods for the treatement of immune related diseases

Publications (2)

Publication Number Publication Date
JP2005519590A JP2005519590A (ja) 2005-07-07
JP2005519590A5 true JP2005519590A5 (enExample) 2006-01-05

Family

ID=40481851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003556018A Pending JP2005519590A (ja) 2001-08-29 2002-07-30 免疫関連疾患の治療のための組成物及び方法

Country Status (10)

Country Link
US (2) US7419799B2 (enExample)
EP (1) EP1472273A4 (enExample)
JP (1) JP2005519590A (enExample)
KR (1) KR20040031031A (enExample)
AU (2) AU2002365246A1 (enExample)
CA (1) CA2458751A1 (enExample)
MX (1) MXPA04001986A (enExample)
NZ (1) NZ531311A (enExample)
WO (1) WO2003055440A2 (enExample)
ZA (1) ZA200401536B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1252333A4 (en) * 2000-01-25 2005-01-05 Nuvelo Inc METHODS AND SUBSTANCES RELATING TO CD84-TYPE POLYPEPTIDES AND POLYNUCLEOTIDES
WO2002077173A2 (en) * 2001-03-22 2002-10-03 Bristol-Myers Squibb Company Polynucleotide encoding a novel immunoglobulin superfamily member, apex4, and variants and splice variants thereof
US7847067B2 (en) * 2006-08-28 2010-12-07 ARCA Biopharma Antibodies to NTB-A
KR100975116B1 (ko) * 2007-12-07 2010-08-11 이영조 가정용 음식물 쓰레기 처리장치의 미생물 공급장치
CN107880126B (zh) 2012-12-21 2021-03-30 西雅图基因公司 抗ntb-a抗体及相关组合物和方法
WO2014171721A1 (ko) * 2013-04-16 2014-10-23 가톨릭대학교 산학협력단 아이케이 인자 및 아이케이 인자를 코딩하는 핵산의 약학적 용도
KR101625112B1 (ko) 2013-04-16 2016-05-27 가톨릭대학교 산학협력단 아이케이 인자 및 아이케이 인자를 코딩하는 핵산의 약학적 용도
EP3091999B2 (en) 2014-01-09 2025-05-07 Hadasit Medical Research Services and Development Ltd. Improved cell compositions and methods for cancer therapy
WO2019155474A1 (en) * 2018-02-12 2019-08-15 Hadasit Medical Research Services & Development Ltd. Modulation of slamf6 splice variants for cancer therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
EP1252333A4 (en) * 2000-01-25 2005-01-05 Nuvelo Inc METHODS AND SUBSTANCES RELATING TO CD84-TYPE POLYPEPTIDES AND POLYNUCLEOTIDES
US7029677B2 (en) * 2000-01-25 2006-04-18 Nuvelo, Inc. Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
US20040034194A1 (en) * 2001-04-11 2004-02-19 Pankaj Agarwal Novel compounds
EP1223218A1 (en) * 2000-11-03 2002-07-17 Millennium Pharmaceuticals, Inc. CD2000 and CD2001 molecules and uses thereof
AU2002257088A1 (en) * 2001-03-12 2002-09-24 Incyte Genomics, Inc. Immunoglobulin superfamily proteins
WO2002077173A2 (en) * 2001-03-22 2002-10-03 Bristol-Myers Squibb Company Polynucleotide encoding a novel immunoglobulin superfamily member, apex4, and variants and splice variants thereof
AU2002325333B2 (en) * 2001-07-19 2008-04-03 Innate Pharma NTB-A, a surface molecule involved in natural killer cells activity

Similar Documents

Publication Publication Date Title
JP2005535290A5 (enExample)
JP2006516094A5 (enExample)
JP2010162017A5 (enExample)
RU2693084C2 (ru) Антитела, направленные против интерлейкина-33 (il-33)
Watanabe et al. Leptin enhances cytokine/chemokine production by normal lung fibroblasts by binding to leptin receptor
JP2010187677A5 (enExample)
JP2007515942A5 (enExample)
Liang et al. Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice
JP2009278998A (ja) チロトロフィン(tsh)受容体の抗原決定領域、その使用およびその抗体
JP2006523682A5 (enExample)
JP2006510619A (ja) 抗炎症剤としてのhmgb断片の使用
CN104159919A (zh) 使用抗干扰素γ抗体的治疗方法
JP2005519590A5 (enExample)
MXPA05012497A (es) Composiciones y metodos para el tratamiento del sindrome respiratorio agudo severo (sars).
JP2021525236A (ja) 抗il12/il23抗体でループスを治療する安全かつ有効な方法
CN101896192A (zh) 一种通过去除或灭活巨噬细胞抑制因子-1而治疗恶病质的方法
EP3157563A1 (en) Compositions and methods for safe and effective immunotherapy
JP2006521082A5 (enExample)
EP2838559B1 (en) Combination therapy of anti-mif antibodies and glucocorticoids
CN106573968B (zh) 糖蛋白激素受体突变
WO2024168965A1 (zh) 人IL-1R1和人IL-1RAcP多肽片段组合的同源二聚体蛋白质与用途
Brigatte et al. Tolerance to the antinociceptive effect of Crotalus durissus terrificus snake venom in mice is mediated by pharmacodynamic mechanisms
WO2025113203A1 (zh) 抗il-31的抗体及其用途
JP2006515748A5 (enExample)
US20250326795A1 (en) Use of d-enantiomeric peptide ligands of monomeric tau for the therapy of various tauopathies